Formosa Laboratories, Inc. (TPE:4746)

Market Cap	6.99B
Revenue (ttm)	4.90B
Net Income (ttm)	240.77M
Shares Out	120.26M
EPS (ttm)	1.99
PE Ratio	29.18
Forward PE	n/a
Dividend	3.00 (5.12%)
Ex-Dividend Date	Aug 21, 2025

Volume	903,960
Average Volume	569,722
Open	58.00
Previous Close	58.10
Day's Range	57.00 - 58.40
52-Week Range	49.50 - 76.80
Beta	0.85
RSI	38.43
Earnings Date	Mar 10, 2026

About Formosa Laboratories

Formosa Laboratories, Inc., together with its subsidiaries, manufactures and sells active pharmaceutical ingredients (APIs) and ultraviolet absorbers in India, the Netherlands, Japan, Germany, Taiwan, China, Switzerland, the United States, Canada, and internationally. The company offers APIs in the areas of anticancer, vitamin D derivatives, anti-inflammatory and analgesic agents, immunomodulators, respiratory agents, cholesterol and phosphate binders, UV filter, iron deficiency anemia (IDA), CNS agents, MRI enhancing agents, steroids, antibiot...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1985
• Employees: 280
• Stock Exchange: Taiwan Stock Exchange
• Ticker Symbol: 4746

Financial Performance

In 2024, Formosa Laboratories's revenue was 4.73 billion, an increase of 8.50% compared to the previous year's 4.36 billion. Earnings were 157.27 million, an increase of 24.58%.